• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CIBA VISION JOHOR SDN, BHD. AIR OPTIX AQUA; LENSES, SOFT CONTACT, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CIBA VISION JOHOR SDN, BHD. AIR OPTIX AQUA; LENSES, SOFT CONTACT, DAILY WEAR Back to Search Results
Catalog Number CBV92001889
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Endophthalmitis (1835); Visual Disturbances (2140); Tingling (2171)
Event Date 08/25/2017
Event Type  Injury  
Manufacturer Narrative
The complaint sample has not returned for evaluation; the lot number is unknown.Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.(b)(4).
 
Event Description
On 09/11/2017, the vigilance department received a report from a pharmacy personnel that a patient experienced tingling after using the contact lenses.It was indicated that a non-alcon lens care solution was used to clean the contact lenses.It was reported that the patient visited an ophthalmologist the following day as the symptoms have aggravated, unknown if treatments were provided.The patient was reportedly hospitalized on (b)(6) 2017 due to no improvement on the patient's symptoms.The reported clinical consequences were pseudomonas abscess under the left eye, endophthalmitis, and decreased visual acuity.Additional information has been requested but not yet received.
 
Manufacturer Narrative
Unopened product from the same lot as the complaint product was returned for evaluation and was found to meet manufacturing specifications.The device history record and sterilization record for this lot have been reviewed and found to be in compliance.The manufacturing review did not indicate that this complaint was due to the manufacturing process.No complaint or manufacturing trend was identified.The root cause could not be determined.(b)(4).
 
Manufacturer Narrative
Unopened product from the complaint lot has been returned for evaluation.Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event Description
Further information received on 10/23/2017 via a completed questionnaire by a pharmacy intern stated that this complaint is in reference to a (b)(6) male patient.The patient had been reportedly hospitalized from (b)(6) 2017 through (b)(6) 2017 and underwent surgical intervention (not specified but reported as a "probable" first amniotic graft membrane) on (b)(6) 2017.It was noted that cultures were taken and were positive to enterobacter cloacae, raoultella plauticola, and pseudomonas aeruginosa.It was further stated that on (b)(6) 2017, the patient underwent a second amniotic membrane graft on the left eye in a context of a pseudomonas corneal abscess.Technical and procedure of the intervention include the following: debridement of the operating site; hand washing with soft soap and hydro alcoholic solution; surgery gloves; betadine disinfection in the eyelids, ciliary edge and conjunctival culs-de-sacs; operating drape to incise stuck, opened eyelids; installation of surgical microscope decontaminated with ultraviolet and steril lens filter; positioning of first and second layers of amniotic membrane graft hold by peri limbic vicryl 8.0 seam in conjunctive; shell and dressing.It was indicated that the patient was prescribed with ceftazidime eye drop one drop eight times daily, amikacin eye drop one drop eight times daily, and atropine 1% one drop three times daily.It was reported that the event had resolved with treatment.
 
Manufacturer Narrative
Catalog number updated to cbv92001889.Manufacturer report number corrected and reported under mfg report num.3006186389-2018-00002, (b)(4).All future follow up regulatory reports will be linked to this updated manufacturing number.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AIR OPTIX AQUA
Type of Device
LENSES, SOFT CONTACT, DAILY WEAR
Manufacturer (Section D)
CIBA VISION JOHOR SDN, BHD.
#1 dpb/5 tanjung pelepas port
gelang patah
johor darul takzim johor IL 81560
MY  81560
MDR Report Key6913703
MDR Text Key88138980
Report Number1422160-2017-00015
Device Sequence Number1
Product Code LPL
Combination Product (y/n)N
PMA/PMN Number
K073459
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Type of Report Initial,Followup,Followup,Followup
Report Date 03/01/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/04/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date11/30/2021
Device Catalogue NumberCBV92001889
Device Lot Number10338142
Other Device ID Number000000000010042532-155673400
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/02/2017
Date Manufacturer Received02/28/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
MULTIPURPOSE CONTACT LENS SOLUTION; MULTIPURPOSE CONTACT LENS SOLUTION
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age16 YR
Patient Weight55
-
-